New Alzheimer’s-Associated Genes

A GWAS meta-analysis identifies 11 new loci associated with onset of the neurodegenerative disease.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Amyloid plaque formations in the brain of a deceased Alzheimer’s patientWIKIMEDIA, JENSFLORIANA meta-analysis of four previously published genome-wide association studies (GWAS) consisting of 17,008 Alzheimer's disease (AD) cases and 37,154 controls has yielded 11 new AD-associated genes. An international team led by investigators at France’s INSERM reported in Nature Genetics this week (October 27) on 11 previously unrecognized susceptibility loci for late-onset AD, which hint at a role for the immune system in the development of the neurodegenerative disease.

According to BBC News, “Alzheimer’s Research UK said the findings could ‘significantly enhance’ understanding of the disease.”

Study coauthor Julie Williams from Cardiff University in the U.K. told the BBC that in analyzing such a large data set, “we've doubled the number of genes discovered and a very strong pattern is emerging. . . . There is something in the immune response which is causing Alzheimer's disease and we need to look at that.”

The National Institute on Aging’s Marilyn Miller lauded the study’s size in an interview with The Washington Post. “Alzheimer’s is obviously a complex disease,” she told the Post, “and because it is so complex, it is only because of this broad-based collaborative effort that we’ve been able to begin to find ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies